A study on the pharmaceutical companies of DSE listed firms of Bangladesh for the period of 2018 to 2022
This internship report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Business Administration, 2023.
第一著者: | Sushme, Sumaiya Selim |
---|---|
その他の著者: | Haque, Mohammad Mujibul |
フォーマット: | Internship report |
言語: | English |
出版事項: |
Brac University
2024
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/22882 |
類似資料
-
Disclosure and compliance of IAS 16 in DSE listed pharmaceuticals companies in Bangladesh
著者:: Al-Mumen, Sk. Abdullah
出版事項: (2018) -
Empirical evidence of CAPM model at pharmaceutical industry of DSE
著者:: Islam, Md. Tariqul
出版事項: (2024) -
Response of market price relative to fundamentals of stocks : a case based approach on pharmaceutical industry listed in DSE
著者:: Faruquee, Murtaza
出版事項: (2013) -
Empirical analysis of 5 DSE equity traded through IDLC Investments Ltd & portfolio management
著者:: Ismail, Mohammed
出版事項: (2017) -
In-plant training at Healthcare Pharmaceuticals Limited
著者:: Rashid, Nowrin, 等
出版事項: (2021)